[ Price : $8.95]
FDA lifts its clinical hold on a Greenwich LifeSciences Phase 3 trial of the companys invasive breast cancer investigational treat...[ Price : $8.95]
Catalyst says it has settled its patent litigation with Jacobus over Catalysts Firdapse and Jacobus Ruzurgi.[ Price : $8.95]
Federal Register notice: FDA extends the comment period on a draft guidance entitled Risk Management Plans to Mitigate the Potenti...[ Price : $8.95]
FDA warns Elite Supplement Center that it is illegally marketing selective androgen receptor modulator products that are legally c...[ Price : $8.95]
FDA accepts for review a Byondis BLA for SYD985 ([vic-] trastuzumab duocarmazine) for use in patients with HER2-positive unresecta...[ Price : $8.95]
FDA grants an emergency use authorization to Watmind USA for its over-the-counter at-home Covid-19 antigen test.[ Price : $8.95]
Federal Register notice: FDA revokes an Emergency Use Authorization issued to Fresenius Kabi USA for its Fresenius Propoven 2% Emu...[ Price : $8.95]
Federal Register notice: FDA withdraws approval of 31 ANDAs from multiple applicants because the products are no longer marketed.